Spark Therapeutics, Inc. (ONCE): http://m.seekingalpha.com/article/293505...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Spark Therapeutics, Inc. (ONCE)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	10
Posts	671
Boards Moderated	0
Alias Born	01/18/2011

Re: None

Sunday, 02/22/2015 11:52:03 AM

Sunday, February 22, 2015 11:52:03 AM

http://m.seekingalpha.com/article/2935056-ipo-quiet-period-expiration-spark-therapeutics-inc

Summary

ONCE develops gene therapy that targets debilitating genetic diseases.
The 25-day quiet period on ONCE will end 2.24.2015, allowing its IPO underwriters to publish reports and recommendations for the first time; this could lead to an uptick in price.
Recent research shows above-market returns in the days surrounding a firm's quiet period expiration, particularly for firm with strong underwriters, like ONCE.
We suggest investors strongly consider buying into ONCE, ahead of the event, for full gains.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ONCE News

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/26/2024 09:26:49 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/11/2024 08:43:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2024 08:05:21 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 08:05:17 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/13/2024 08:59:10 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/27/2024 09:31:17 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:05:11 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/14/2024 10:06:02 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/14/2024 10:04:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:24:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:30:14 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/01/2024 10:09:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:30:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:05:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:51:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:00:40 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/27/2023 09:51:05 PM

More ONCE News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow